Outcomes comparison of HeRO and lower extremity arteriovenous grafts in patients with long-standing renal failure

Steerman, Samuel; Wagner, Jason K.; Higgins, Jonathan A.; Kim, Claudia; Mirza, Aleem K.; Pavela, James; Panneton, Jean M.; Glickman, Marc H.

doi:10.1016/j.jvs.2012.09.040

Cited by 45 publications

(41 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Despite comparable patencies the infection rate in the LLAVG was 29%, which was almost twice that of the HeRO rate. Steerman et al 7 describe similar rates of patency with no difference in infection between LLAVG and HeRO; however, selection bias with respect to BMI is stated. Those patients with higher body mass index in the HeRO group would be much higher risk of graft infection which may explain the differences in the studies.…”

Section: Discussionmentioning

confidence: 97%

A Review on the Hemodialysis Reliable Outflow (HeRO) Graft for Haemodialysis Vascular Access

Shakarchi

Houston

Jones³

et al. 2015

European Journal of Vascular and Endovascular Surgery

View full text Add to dashboard Cite

This literature review shows that the HeRO graft is an acceptable option for complex dialysis patients who are catheter dependent. Owing to device availability, published data are predominantly North American and further longer-term studies in other populations may be necessary. In this challenging patient group, randomized controlled trials are required to allow comparisons with alternative access options.

show abstract

Section: Discussionmentioning

confidence: 97%

A Review on the Hemodialysis Reliable Outflow (HeRO) Graft for Haemodialysis Vascular Access

Shakarchi

Houston

Jones³

et al. 2015

European Journal of Vascular and Endovascular Surgery

View full text Add to dashboard Cite

show abstract

“…The HeRO graft represents an effective option for patients without any suitable upper extremity veins for access creation. The patency of the HeRO graft is comparable to that of the conventional graft and thigh graft , and the annual cost of the HeRO graft maintenance is moreover less than that of a tunneled catheter or thigh graft . However, there are also several disadvantages of HeRO grafts.…”

Section: Discussionmentioning

confidence: 91%

Catheter‐directed Thrombolysis in Acute Superior Vena Cava Syndrome Caused by Central Venous Catheters

Cui

Kawai

Irani

2015

Seminars in Dialysis

View full text Add to dashboard Cite

Indwelling central venous catheters have been reported to increase the risk of superior venous cava (SVC) syndrome. This case report describes the development of acute SVC syndrome in a 28-year-old woman with end-stage renal disease implanted with a left-side hemodialysis reliable outflow graft and a right-side double lumen hemodialysis catheter via internal jugular veins. Her symptoms were not alleviated after catheter removal and systemic anticoagulation therapy. She was eventually treated with catheter-directed thrombolysis and a predischarge computer tomographic venogram on postthrombolytic procedure day 7 showed patent central veins and patient remained asymptomatic. This case demonstrates that catheter-directed thrombolysis can be safely employed to treat refractory catheter-induced acute SVC syndrome in end-stage renal disease patients.

show abstract

“…If there is no suitable superficial vein, prosthetic AV fistula or brachiobasilic AV fistula with basilic vein transposition are required (23,24). However, if the upper limb use is not appropriate, axillary-axillary AV access (necklace graft) (25), superficial femoral vein transposition (26), axillary artery to right atrial graft (27), hemodialysis reliable outflow graft (28), and femoral AV graft could be used as alternative choices for vascular access (19)(20)(21). Autogenous AV fistula or graft AV fistula are available for femoral AV access, although the former is not preferred because of wide incision and associated complications (19,29,30).…”

Section: Discussionmentioning

confidence: 99%

Percutaneous transluminal angioplasty for dysfunctional femoral hemodialysis graft

Kim²,

Goo³

et al. 2015

Diagn Interv Radiol

View full text Add to dashboard Cite

ORIGINAL ARTICLE PURPOSE We aimed to evaluate the safety and effectiveness of percutaneous transluminal angioplasty (PTA) for dysfunctional femoral arteriovenous graft and analyze clinical or anatomic predictors of graft patency. METHODSThe records of 45 patients who underwent PTA or thromboaspiration for dysfunctional or thrombosed femoral arteriovenous graft from 2005 to 2012 were reviewed retrospectively. Primary and secondary patency rates were determined at three, six, and 12 months after PTA. The primary patency rate was analyzed according to the presence of diabetes mellitus, graft age from the time of creation to the first intervention (<12 months or ≥12 months), presence of thrombus, shape of graft (U-shape vs. straight-shape), anastomosis type of graft (femoral-femoral vs. femoral-saphenous), location of stenosis (central vs. peripheral), length of stenosis (<2 cm vs. ≥2 cm), degree of stenosis severity (<70% vs. ≥70%), and stent insertion. RESULTSA total of 124 PTAs were performed in 45 patients. The primary patency rate at three, six, and 12 months was 84.8%, 63.6%, and 24.2%, respectively. The secondary patency rate at three, six, and 12 months was 95.2%, 95.2%, and 85.7%, respectively. The mean duration of primary and secondary patency was 13.2 and 35.7 months, respectively. No significant clinical or anatomical predictors of primary patency could be identified. Stent placement had a negative effect on primary patency. CONCLUSION PTA is a safe and effective treatment for dysfunctional femoral arteriovenous grafts. Stent placement seems to improve technical success, but does not enhance the primary patency rate of dysfunctional femoral arteriovenous grafts.

show abstract

Outcomes comparison of HeRO and lower extremity arteriovenous grafts in patients with long-standing renal failure

Cited by 45 publications

References 14 publications

A Review on the Hemodialysis Reliable Outflow (HeRO) Graft for Haemodialysis Vascular Access

A Review on the Hemodialysis Reliable Outflow (HeRO) Graft for Haemodialysis Vascular Access

Catheter‐directed Thrombolysis in Acute Superior Vena Cava Syndrome Caused by Central Venous Catheters

Percutaneous transluminal angioplasty for dysfunctional femoral hemodialysis graft

Contact Info

Product

Resources

About